Therapeutic Targeting of CD95 and the TRAIL Death Receptors

Publisher： Bentham Science Publishers

E-ISSN： 2212-3970|6|3|294-310

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.6, Iss.3, 2011-09, pp. : 294-310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The CD95 system and the death of a lymphocyte

By Matiba B.   Mariani S.M.   Krammer P.H.  

Seminars in Immunology, Vol. 9, Iss. 1, 1997-01 ,pp. : 59-68

Academic Press

Access to resources Recommend Favorite

Targeting Cell Death and Survival Receptors in Hepatocellular Carcinoma

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 6, 2011-07 ,pp. : 576-584

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of a methylation hotspot in the death receptor Fas/CD95 in bladder cancer

By                    

International Journal of Oncology, Vol. 40, Iss. 3, 2012-01 ,pp. : 645-654

Spandidos Publications

Access to resources Recommend Favorite

Homoharringtonine and SAHA synergistically enhance apoptosis in human acute myeloid leukemia cells through upregulation of TRAIL and death receptors

By          

Molecular Medicine Reports, Vol. 7, Iss. 6, 2013-01 ,pp. : 1838-1844

Spandidos Publications

Access to resources Recommend Favorite

Therapeutic targeting of CD19 in hematological malignancies: past, present, future and beyond

By Katz Ben-Zion   Herishanu Yair  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 999-1006

Informa Healthcare

Access to resources Recommend Favorite